FTC 200mg+TDF 300mg tabs/PAC-30
Emtricitabine 200mg + Tenofovir disoproxil fumarate 300mg, equivalent to 245mg Tenofovir disoproxil, film coated tablets, in bottle pack of 30
Indicative Price : Upon Request
NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: firstname.lastname@example.org
Emtricitabine 200mg + Tenofovir 300mg Tablets, pack of 30
Each film coated tablet contains Emtricitabine 200mg and Tenofovir Disoproxil Fumarate 300mg which is equivalent to 245mg of Tenofovir Disoproxil as fixed dose combination (FDC).
Emtricitabine is a Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Tenofovir is a Nucleotide Reverse Transcriptase Inhibitor (NtRTI)
Standard shelf life:
2 years (24 months)
Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.
Guidelines for use:
For more details, please click the links listed below:
WHO treatment guidelines
WHO Essential Medicines Library
or your regional national guidelines
For details about paediatric dosage schemes, please click the links listed below:
WHO Generic tool for assessing paediatric ARV dosing
Management of HIV-1 infection in adults in combination with at least one other antiretroviral drug. By mouth (oral), PO
Do not store above 30ºC (86ºF).
Store in a tightly closed container.
Keep out of reach and sight of children.
Dispense in original container. Do not repack
Can be taken with or without food
For latest updates, please click the links listed below:
List of WHO Prequalified Medicines
List of USFDA approved and tentatively approved items
|To see icon descriptions, go to |
' Product attribute guide'